JP2013522184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013522184A5 JP2013522184A5 JP2012556592A JP2012556592A JP2013522184A5 JP 2013522184 A5 JP2013522184 A5 JP 2013522184A5 JP 2012556592 A JP2012556592 A JP 2012556592A JP 2012556592 A JP2012556592 A JP 2012556592A JP 2013522184 A5 JP2013522184 A5 JP 2013522184A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- temozolomide
- phytocannabinoid
- phytocannabinoids
- glioma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temodal Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 claims 6
- 229960004964 temozolomide Drugs 0.000 claims 6
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N Cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 4
- 229950011318 Cannabidiol Drugs 0.000 claims 4
- QHMBSVQNZZTUGM-MSOLQXFVSA-N Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-MSOLQXFVSA-N 0.000 claims 4
- 206010018338 Glioma Diseases 0.000 claims 4
- 229940033529 Tetrahydrocannabinol Drugs 0.000 claims 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 4
- 229960004242 dronabinol Drugs 0.000 claims 4
- 241001483078 Phyto Species 0.000 claims 2
- 230000002149 cannabinoid Effects 0.000 claims 2
- 229930003827 cannabinoid Natural products 0.000 claims 2
- 239000003557 cannabinoid Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
Claims (4)
- 神経膠腫の治療における使用のための、テモゾロミドとフィトカンナビノイドとの組合せであって、
フィトカンナビノイドが、テトラヒドロカンナビノール(THC)及びカンナビジオール(CBD)であり、
前記フィトカンナビノイド及び/又はテモゾロミドの用量レベルが、単独で使用した場合には神経膠腫の治療に対して効果的なレベルに満たないものである、
組合せ。 - 神経膠腫を治療する薬物の生産における、テモゾロミドとフィトカンナビノイドとの組合せの使用であって、
フィトカンナビノイドが、テトラヒドロカンナビノール(THC)及びカンナビジオール(CBD)であり、
前記フィトカンナビノイド及び/又はテモゾロミドの用量レベルが、単独で使用した場合には神経膠腫の治療に対して効果的なレベルに満たないものである、
組合せの使用。 - 前記フィトカンナビノイドと前記テモゾロミドとの組合せが、別々に、同時に又は連続的に投与するためにパッケージングされる、請求項1に記載のフィトカンナビノイドの組合せ。
- 前記フィトカンナビノイドと前記テモゾロミドとの組合せが、別々に、同時に又は連続的に投与するためにパッケージングされる、請求項2に記載のフィトカンナビノイドの組合せの使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1004137.4A GB2478595B (en) | 2010-03-12 | 2010-03-12 | Phytocannabinoids in the treatment of glioma |
GB1004137.4 | 2010-03-12 | ||
PCT/GB2011/050487 WO2011110866A1 (en) | 2010-03-12 | 2011-03-11 | Phytocannabinoids in the treatment of cancer |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2013522184A JP2013522184A (ja) | 2013-06-13 |
JP2013522184A5 true JP2013522184A5 (ja) | 2014-04-24 |
JP5785569B2 JP5785569B2 (ja) | 2015-09-30 |
Family
ID=42261478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012556592A Active JP5785569B2 (ja) | 2010-03-12 | 2011-03-11 | がんの治療におけるフィトカンナビノイド |
Country Status (27)
Country | Link |
---|---|
US (3) | US8790719B2 (ja) |
EP (1) | EP2544682B1 (ja) |
JP (1) | JP5785569B2 (ja) |
KR (1) | KR20130067248A (ja) |
CN (1) | CN102869356A (ja) |
AR (1) | AR080454A1 (ja) |
AU (3) | AU2011225837A1 (ja) |
BR (1) | BR112012023017A8 (ja) |
CA (1) | CA2792722A1 (ja) |
CO (1) | CO6630103A2 (ja) |
CY (1) | CY1117451T1 (ja) |
DK (1) | DK2544682T3 (ja) |
EA (1) | EA201290901A1 (ja) |
ES (1) | ES2569669T3 (ja) |
GB (1) | GB2478595B (ja) |
HR (1) | HRP20160427T1 (ja) |
HU (1) | HUE029817T2 (ja) |
IL (1) | IL221871A (ja) |
MX (1) | MX2012010512A (ja) |
NZ (2) | NZ629136A (ja) |
PL (1) | PL2544682T3 (ja) |
SG (1) | SG184016A1 (ja) |
SI (1) | SI2544682T1 (ja) |
TW (1) | TWI461205B (ja) |
UA (1) | UA109271C2 (ja) |
WO (1) | WO2011110866A1 (ja) |
ZA (1) | ZA201207574B (ja) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2377218A (en) * | 2001-05-04 | 2003-01-08 | Gw Pharmaceuticals Ltd | Process and apparatus for extraction of active substances and enriched extracts from natural products |
GB0425248D0 (en) | 2004-11-16 | 2004-12-15 | Gw Pharma Ltd | New use for cannabinoid |
WO2006054057A2 (en) | 2004-11-16 | 2006-05-26 | Gw Pharma Limited | New use for cannabinoid |
GB2460672B (en) * | 2008-06-04 | 2012-01-04 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agents that are alkylating agents |
GB2471523A (en) | 2009-07-03 | 2011-01-05 | Gw Pharma Ltd | Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
GB2494461A (en) * | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
GB2514054A (en) * | 2011-09-29 | 2014-11-12 | Gw Pharma Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
GB201117956D0 (en) * | 2011-10-18 | 2011-11-30 | Otsuka Pharma Co Ltd | Phytocannabinoids for use in the treatment of breast cancer |
US9776014B2 (en) | 2012-05-03 | 2017-10-03 | Magdent Ltd. | Bone enhancement device and method |
EP2934512B1 (en) | 2012-12-18 | 2021-11-24 | Kotzker Consulting LLC | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
BR112015020332A2 (pt) | 2013-02-28 | 2017-07-18 | Full Spectrum Laboratories Ltd | processos de engenharia química e aparelhos para a síntese de compostos |
CA2904968A1 (en) | 2013-03-14 | 2014-10-02 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
WO2014145490A2 (en) | 2013-03-15 | 2014-09-18 | Biotech Institute, Llc | Breeding, production, processing and use of specialty cannabis |
US10441617B2 (en) | 2013-03-15 | 2019-10-15 | Biotech Institute, Llc | Breeding, production, processing and use of medical cannabis |
GB2513167B (en) * | 2013-04-18 | 2016-03-02 | Otsuka Pharma Co Ltd | Tetrahydrocannabivarin for use in the treatment of nausea and vomiting |
GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
US10774288B2 (en) * | 2013-09-18 | 2020-09-15 | The Werc Shop, LLC | Terpene-based compositions, processes, methodologies for creation and products thereby |
AU2014347807A1 (en) * | 2013-10-31 | 2016-05-26 | Full Spectrum Laboratories, Ltd. | Terpene and cannabinoid formulations |
GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
GB2527590A (en) * | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
GB2527599A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
WO2016014454A1 (en) | 2014-07-21 | 2016-01-28 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal or sublingual administration of cannabinoids |
JP6622793B2 (ja) | 2014-08-25 | 2019-12-18 | ティーウィノット テクノロジーズ リミテッド | カンナビノイド化合物を同時作製する装置及び方法 |
CA2961410C (en) | 2014-09-16 | 2023-07-11 | India Globalization Capital, Inc. | Cannabinoid composition and method for treating pain |
US9844518B2 (en) | 2014-09-30 | 2017-12-19 | MJAR Holdings, LLC | Methods of growing cannabaceae plants using artificial lighting |
GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
GB2531278A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
CN107205960A (zh) * | 2014-10-21 | 2017-09-26 | 联合大麻公司 | 大麻提取物及其制备和使用方法 |
CN104277917B (zh) * | 2014-10-24 | 2018-02-09 | 汉康(云南)生物科技有限公司 | 一种富含大麻二酚的工业大麻精油提取方法及其提取设备 |
US10502750B2 (en) | 2014-12-23 | 2019-12-10 | Biotech Institute, Llc | Reliable and robust method for the analysis of cannabinoids and terpenes in cannabis |
WO2016118391A1 (en) | 2015-01-25 | 2016-07-28 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
CA3012599A1 (en) | 2015-01-26 | 2016-08-04 | Matthew W. Giese | Systems, apparatuses, and methods for classification |
EP3250200A4 (en) | 2015-01-31 | 2018-09-19 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
US10238745B2 (en) | 2015-01-31 | 2019-03-26 | Constance Therapeutics, Inc. | Cannabinoid composition and products including α-tocopherol |
CN107405314A (zh) * | 2015-02-27 | 2017-11-28 | 埃布公司 | 包含纯化的大麻素与至少一种类黄酮、萜或矿物质的组合的组合物 |
US20160250270A1 (en) | 2015-02-27 | 2016-09-01 | Ebbu, LLC | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
WO2016157192A1 (en) | 2015-04-01 | 2016-10-06 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Erodium crassifolium l'her plant extracts and uses thereof |
EP3291807B1 (en) * | 2015-05-07 | 2019-09-25 | Mark Andrew Scialdone | Hydrogenation of cannabis oil |
GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
US11369655B2 (en) | 2015-07-06 | 2022-06-28 | Cg-Bio Genomics, Inc. | Healthful supplements |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
GB2541191A (en) | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
US10596159B2 (en) | 2015-08-12 | 2020-03-24 | India Globalization Capital, Inc. | Method and composition for treating cachexia and eating disorders |
MX2018006381A (es) | 2015-11-24 | 2019-02-14 | Constance Therapeutics Inc | Composiciones de aceite de cannabis y metodos para preparacion de las mismas. |
MX2018011348A (es) * | 2016-03-18 | 2019-07-12 | Brian Reid Christopher | Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades. |
GB2548873B (en) | 2016-03-31 | 2020-12-02 | Gw Res Ltd | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
CA3027862A1 (en) | 2016-06-15 | 2017-12-21 | India Globalization Capital, Inc. | Method and composition for treating seizure disorders |
GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
JP2019523282A (ja) * | 2016-08-03 | 2019-08-22 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 大麻組成物 |
KR20220132674A (ko) * | 2016-08-03 | 2022-09-30 | 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 카나비스 조성물 |
CA3031810A1 (en) * | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
GB2553139A (en) | 2016-08-25 | 2018-02-28 | Gw Res Ltd | Use of cannabinoids in the treatment of multiple myeloma |
CN110177543A (zh) | 2016-08-29 | 2019-08-27 | 凯诺比生长公司 | 包含纯化大麻素的水溶性组合物 |
GB2557921A (en) | 2016-12-16 | 2018-07-04 | Gw Res Ltd | Use of cannabinoids in the treatment of angelman syndrome |
GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
BR112019018088A2 (pt) * | 2017-03-01 | 2020-03-24 | Canopy Growth Corporation | Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados |
CN110799186A (zh) | 2017-03-05 | 2020-02-14 | 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 | 治疗炎性疾病的组合物和方法 |
WO2018205038A1 (en) * | 2017-05-12 | 2018-11-15 | Tetra Bio-Pharma Inc. | Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling |
WO2018217803A2 (en) | 2017-05-22 | 2018-11-29 | Growblox Life Sciences L.L.C. | Myrcene-containing complex mixtures targeting trpv1 |
EP3509638B1 (en) | 2017-06-20 | 2022-01-12 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Cannabidiolic acid esters compositions and uses thereof |
WO2019003163A2 (en) * | 2017-06-28 | 2019-01-03 | Buzzelet Development And Technologies Ltd. | CANNABINOID PRODUCT ENRICHED IN TERPENE GOOD FOR WOMEN'S HEALTH |
CN111629724A (zh) * | 2017-09-02 | 2020-09-04 | 科学控股公司 | 四氢大麻酚调节剂 |
GB2569961B (en) | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
CN108204786A (zh) * | 2018-01-15 | 2018-06-26 | 武汉盛硕电子有限公司 | 一种基于手机模块的北斗测量系统 |
US10688191B2 (en) | 2018-01-19 | 2020-06-23 | Hr Biomed, Llc | Delivery of a chemotherapy agent across the blood-brain barrier |
EP3743061A1 (en) * | 2018-01-22 | 2020-12-02 | Pascal Biosciences Inc. | Cannabinoids and derivatives for promoting immunogenicity of tumor and infected cells |
JP7325425B2 (ja) * | 2018-02-08 | 2023-08-14 | ネオンク テクノロジーズ インク. | 血液脳関門を透過性にする方法 |
KR102041875B1 (ko) | 2018-02-14 | 2019-11-08 | (주)카이언바이오텍 | 대마로부터 추출된 칸나비디올 추출물 및 트레일을 함유하는 대장암 예방 또는 치료용 약학 조성물 |
KR20190098649A (ko) | 2018-02-14 | 2019-08-22 | (주)카이언바이오텍 | 칸나비디올 추출물을 함유하는 대장암 예방 또는 치료용 약학 조성물 |
PL3755318T3 (pl) * | 2018-02-20 | 2022-12-19 | Mymd Pharmaceuticals, Inc. | Genetycznie zmodyfikowane rośliny cannabis sativa i zmodyfikowane związki kannabinoidowe do leczenia uzależnień od substancji i innych zaburzeń |
US11607423B2 (en) | 2018-04-04 | 2023-03-21 | Akos Biosciences, Inc. | Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer |
JP2021521277A (ja) | 2018-04-09 | 2021-08-26 | エレヴェット・サイエンシズ | 動物における疼痛の処置のためのアサ抽出物 |
WO2019227167A1 (en) * | 2018-06-01 | 2019-12-05 | The University Of Sydney | Compositions and treatments |
WO2020012315A1 (en) * | 2018-07-08 | 2020-01-16 | Buzzelet Development And Technologies Ltd. | Terpene-enriched cannabinoid composition for treatment of male subjects |
EP3666765A1 (en) * | 2018-12-11 | 2020-06-17 | Emerald Health Biotechnology España,S.L.U. | Chromenic phytocannabinoids, their synthesis and use in treatment or prevention of disease |
CA3123773A1 (en) * | 2018-12-12 | 2020-06-18 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl) |
JP2022523338A (ja) * | 2019-01-31 | 2022-04-22 | カヴァ ヘルスケア インコーポレイテッド | Mhc-i発現を増加させ、およびヒストンデアセチラーゼ活性を調節するための化合物 |
NL2022614B1 (en) * | 2019-02-21 | 2020-08-31 | Patrick Alexander Unger | Pharmaceutical, phyto-cannabinoid based compositions |
EP3946307A4 (en) * | 2019-04-02 | 2022-12-14 | Ulagaraj Selvaraj | SOLID NANOPARTICLE FORMULATION OF WATER-INSOLUBLE PHARMACEUTICAL SUBSTANCES WITH REDUCED OSTWALD RIPENING AND IMMEDIATE DRUG RELEASE AFTER INTRAVENOUS ADMINISTRATION |
AU2020268218B2 (en) * | 2019-05-03 | 2022-09-08 | Zyus Life Sciences Inc. | Formulation for pain management |
CA3140290A1 (en) * | 2019-05-16 | 2020-11-19 | Technion Research & Development Foundation Limited | Cannabinoids and uses thereof |
GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
CN111184710A (zh) * | 2020-03-02 | 2020-05-22 | 福建省中科生物股份有限公司 | 一种环酚的应用和制备方法 |
US20220226259A1 (en) | 2020-04-29 | 2022-07-21 | Vivacell Biotechnology España S.L. | Cannabinoids for use in supressing cancer stem cells |
EP3912485A1 (en) | 2020-05-18 | 2021-11-24 | Del-Vis Sp. z o.o. | Cigarette product and a method for manufacturing the product |
CN111773390B (zh) * | 2020-07-01 | 2021-08-20 | 南京大学 | 一种药物在制备治疗脑转移瘤及其相关疾病的药品中的应用 |
EP4203925A1 (en) * | 2020-08-31 | 2023-07-05 | Nelson Mandela University | Cannabinoid combinations and their use in the treatment of cancer |
US11160757B1 (en) | 2020-10-12 | 2021-11-02 | GW Research Limited | pH dependent release coated microparticle cannabinoid formulations |
EP4259122A1 (en) * | 2020-12-08 | 2023-10-18 | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) | Compositions and methods for the treatment of urothelial cancer |
IL307444A (en) * | 2021-04-05 | 2023-12-01 | The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo | Preparations and methods for the treatment of cancer |
CA3217137A1 (en) | 2021-04-29 | 2022-11-03 | Christopher Adair | Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof |
KR20240116462A (ko) | 2021-10-26 | 2024-07-29 | 더 유니버시티 오브 뉴캐슬 | 대마 추출물로 난소암을 치료하는 방법 |
IL312245A (en) | 2021-10-26 | 2024-06-01 | Ecofibre Usa Inc | Methods of treating endometriosis and other non-cancerous gynecological disorders with hemp extract |
AU2022376837A1 (en) | 2021-10-26 | 2024-05-23 | Ecofibre USA Inc. | Systems and methods for producing hemp extracts and compositions |
WO2023130160A1 (en) * | 2022-01-10 | 2023-07-13 | Dolce Cann Global Pty Ltd | Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda). |
WO2023130161A1 (en) * | 2022-01-10 | 2023-07-13 | Dolce Cann Global Pty Ltd | Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda) along with an additional active agent |
WO2023161921A2 (en) * | 2022-02-23 | 2023-08-31 | Cannabotech Ltd. | Compositions for use as an adjunctive therapy in the treatment of breast cancer |
WO2023239415A1 (en) * | 2022-06-08 | 2023-12-14 | Angrow Company Limited | Compositions including cannabinoid and use thereof in the manufacture of a medicament for the treatment of inflammation in a subject |
WO2023238114A1 (en) * | 2022-06-08 | 2023-12-14 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Institute) | Combinations and methods for the treatment of cancer |
WO2024082014A1 (en) * | 2022-10-21 | 2024-04-25 | Dolce Cann Global Pty Ltd | Compositions comprising cannabidiolic acid and fatty acids |
WO2024091989A1 (en) | 2022-10-26 | 2024-05-02 | Ecofibre USA Inc. | Stabilized compositions comprising cannabidiol |
WO2024091987A1 (en) | 2022-10-26 | 2024-05-02 | Ecofibre USA Inc. | Methods of treating estrogen sensitive diseases with cannabis extract |
CN115583933B (zh) * | 2022-10-31 | 2024-02-06 | 暨明医药科技(苏州)有限公司 | 一种高纯度四氢大麻素同系物的制备方法 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2238707A (en) | 1989-12-08 | 1991-06-12 | Peter Bullock | Repairing footwear |
US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
ES1045342Y (es) | 2000-02-11 | 2001-02-16 | Alvarez Manuel Couto | Expositor giratorio para postales, fotos y similares. |
ES2164584A1 (es) | 2000-02-11 | 2002-02-16 | Univ Madrid Complutense | Terapia con cannabinoides para el tratamiento de tumores cerebrales. |
US20040039048A1 (en) | 2000-02-11 | 2004-02-26 | Manuel Guzman Pastor | Therapy with cannabinoid compounds for the treatment of brain tumors |
US6448288B1 (en) | 2000-05-17 | 2002-09-10 | University Of Massachusetts | Cannabinoid drugs |
AU2001290949A1 (en) | 2000-09-14 | 2002-03-26 | California Pacific Medical Center | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
DE10051427C1 (de) | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
GB2380129B (en) | 2001-02-14 | 2004-08-11 | Gw Pharma Ltd | Pharmaceutical formulations |
US7025992B2 (en) | 2001-02-14 | 2006-04-11 | Gw Pharma Limited | Pharmaceutical formulations |
CH695661A5 (de) | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
GB0202385D0 (en) | 2002-02-01 | 2002-03-20 | Gw Pharma Ltd | Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions |
US8034843B2 (en) * | 2002-02-01 | 2011-10-11 | Gw Pharma Limited | Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
US20080057117A1 (en) | 2002-02-15 | 2008-03-06 | Forschungs Institut Miscia Verenfur Krebsforschung | Pharmaceutical composition made up of cannibus extracts |
IL148244A0 (en) | 2002-02-19 | 2002-09-12 | Yissum Res Dev Co | Anti-nausea and anti-vomiting activity of cannabidiol compounds |
CA2483072A1 (en) | 2002-04-25 | 2003-11-06 | Virginia Commonwealth University | Cannabinoids |
GB2391865B (en) | 2002-08-14 | 2005-06-01 | Gw Pharma Ltd | Improvements in the extraction of pharmaceutically active components from plant materials |
US6946150B2 (en) | 2002-08-14 | 2005-09-20 | Gw Pharma Limited | Pharmaceutical formulation |
GB2394894B (en) | 2002-11-04 | 2005-08-31 | G W Pharma Ltd | New use for pharmaceutical composition |
GB2414933B (en) | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
GB2418612A (en) | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
ATE440117T1 (de) | 2005-04-01 | 2009-09-15 | Intezyne Technologies Inc | Polymermicellen für die arzneistoffzufuhr |
US7968594B2 (en) | 2005-04-27 | 2011-06-28 | Gw Pharma Limited | Pharmaceutical compositions for the treatment of pain |
MX2007014188A (es) | 2005-05-13 | 2008-02-05 | Unimed Pharmaceuticals Inc | Tratamiento con dronabinol de nauseas y vomitos tardios inducidos por quimioterapia. |
GB2434312B (en) * | 2006-01-18 | 2011-06-29 | Gw Pharma Ltd | Cannabinoid-containing plant extracts as neuroprotective agents |
GB2438682A (en) | 2006-06-01 | 2007-12-05 | Gw Pharma Ltd | New use for cannabinoids |
GB2439393B (en) | 2006-06-23 | 2011-05-11 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
US20080103193A1 (en) * | 2006-10-26 | 2008-05-01 | Trevor Percival Castor | Methods for making compositions and compositions for treating pain and cachexia |
JP2010520269A (ja) * | 2007-03-05 | 2010-06-10 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム | カンナビノイドの新規キノノイド誘導体及び悪性腫瘍の治療におけるそれらの使用 |
GB2448535A (en) | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
US9084771B2 (en) | 2007-05-17 | 2015-07-21 | Sutter West Bay Hospitals | Methods and compositions for treating cancer |
GB2449691A (en) * | 2007-05-31 | 2008-12-03 | Gw Pharma Ltd | A reference plant lacking medicinal active compound expression |
GB2450741A (en) * | 2007-07-05 | 2009-01-07 | Gw Pharma Ltd | Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease |
EP2044935B1 (en) * | 2007-10-02 | 2011-01-05 | Vivacell Biotechnology Espana S.L. | A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases |
GB2456183A (en) * | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
GB2460672B (en) | 2008-06-04 | 2012-01-04 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agents that are alkylating agents |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
-
2010
- 2010-03-12 GB GB1004137.4A patent/GB2478595B/en active Active
-
2011
- 2011-03-03 AR ARP110100670A patent/AR080454A1/es unknown
- 2011-03-09 TW TW100107897A patent/TWI461205B/zh not_active IP Right Cessation
- 2011-03-11 CN CN2011800236521A patent/CN102869356A/zh active Pending
- 2011-03-11 EP EP11709175.1A patent/EP2544682B1/en active Active
- 2011-03-11 SI SI201130799A patent/SI2544682T1/sl unknown
- 2011-03-11 AU AU2011225837A patent/AU2011225837A1/en not_active Abandoned
- 2011-03-11 JP JP2012556592A patent/JP5785569B2/ja active Active
- 2011-03-11 PL PL11709175T patent/PL2544682T3/pl unknown
- 2011-03-11 EA EA201290901A patent/EA201290901A1/ru unknown
- 2011-03-11 UA UAA201211775A patent/UA109271C2/uk unknown
- 2011-03-11 MX MX2012010512A patent/MX2012010512A/es not_active Application Discontinuation
- 2011-03-11 NZ NZ629136A patent/NZ629136A/en unknown
- 2011-03-11 CA CA2792722A patent/CA2792722A1/en not_active Abandoned
- 2011-03-11 HU HUE11709175A patent/HUE029817T2/en unknown
- 2011-03-11 DK DK11709175.1T patent/DK2544682T3/en active
- 2011-03-11 US US13/634,343 patent/US8790719B2/en active Active
- 2011-03-11 NZ NZ602953A patent/NZ602953A/en unknown
- 2011-03-11 KR KR1020127026659A patent/KR20130067248A/ko not_active Application Discontinuation
- 2011-03-11 ES ES11709175.1T patent/ES2569669T3/es active Active
- 2011-03-11 SG SG2012067393A patent/SG184016A1/en unknown
- 2011-03-11 BR BR112012023017A patent/BR112012023017A8/pt not_active IP Right Cessation
- 2011-03-11 WO PCT/GB2011/050487 patent/WO2011110866A1/en active Application Filing
-
2012
- 2012-09-10 IL IL221871A patent/IL221871A/en active IP Right Grant
- 2012-10-09 CO CO12177686A patent/CO6630103A2/es unknown
- 2012-10-09 ZA ZA2012/07574A patent/ZA201207574B/en unknown
-
2014
- 2014-04-24 US US14/260,876 patent/US9675654B2/en active Active
-
2016
- 2016-04-21 HR HRP20160427TT patent/HRP20160427T1/hr unknown
- 2016-04-27 CY CY20161100356T patent/CY1117451T1/el unknown
- 2016-12-01 AU AU2016266059A patent/AU2016266059A1/en not_active Abandoned
-
2017
- 2017-06-12 US US15/620,435 patent/US20180042975A1/en not_active Abandoned
-
2018
- 2018-08-16 AU AU2018217273A patent/AU2018217273B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2013522184A5 (ja) | ||
BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
IL221871A (en) | Use of a drug containing tetrahydrocannabinol, cannabidiol and tamozolomide for the treatment of glioma | |
CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
JP2012046524A5 (ja) | ||
WO2015054619A3 (en) | Use of a pcsk9 inhibitor to treat hyperlipidemia | |
WO2011088120A8 (en) | Antibody formulation and therapeutic regimens | |
IL223783B (en) | Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine | |
WO2012062925A3 (en) | Compounds and methods for treating pain | |
WO2013170068A3 (en) | Nuclear transport modulators and uses thereof | |
JP2013155188A5 (ja) | ||
WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
WO2009065406A3 (en) | Novel cyclic hydrocarbon compounds for the treatment of diseases | |
UA109650C2 (xx) | Біс-арилзв'язані арилтриазолони та їх застосування | |
IL232308A (en) | Compounds as modulators of atp-linked casting, pharmaceuticals containing them and their use in the preparation of drugs for the treatment of diseases and processes for their preparation | |
EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
CL2014002935A1 (es) | Metodo para tratar un paciente humano con esclerosis multiple con laquinimod, en una dosis diaria de alrededor de 1,2mg; un aforma de dosificacion unitaria oral de 1,2 mg de laquinimod y un portador | |
MX340985B (es) | Compuestos de n-heteroarilo. | |
EA201491281A1 (ru) | КОМПОЗИЦИЯ В ФОРМЕ СУХОГО ПОРОШКА, СОДЕРЖАЩАЯ КОРТИКОСТЕРОИД И β-АДРЕНЕРГИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, ДЛЯ ВВЕДЕНИЯ ИНГАЛЯЦИЕЙ | |
WO2012097264A3 (en) | Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof | |
JP2015537000A5 (ja) | ||
DK2802319T3 (da) | Fastdosiskombinationsterapi for parkinsons sygdom | |
AR098832A1 (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
JP2017061488A5 (ja) |